ConvaTec Group PLC (LON:CTEC)
London · Delayed Price · Currency is GBP · Price in GBp 231.80
-4.00 (-1.70%)
Sep 19, 2025, 4:47 PM BST
ConvaTec Group Market Cap
ConvaTec Group has a market cap or net worth of 4.69 billion as of September 19, 2025. Its market cap has decreased by -1.95% in one year.
Market Cap
4.69B
Enterprise Value
5.59B
Revenue
1.72B
Ranking
n/a
PE Ratio
29.98
Stock Price
231.80
Market Cap Chart
Since October 26, 2016, ConvaTec Group's market cap has increased from 4.39B to 4.69B, an increase of 6.72%. That is a compound annual growth rate of 0.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 4.69B | 3.55% |
| Dec 31, 2024 | 4.53B | -9.11% |
| Dec 29, 2023 | 4.98B | 4.77% |
| Dec 30, 2022 | 4.75B | 22.28% |
| Dec 31, 2021 | 3.89B | -2.42% |
| Dec 31, 2020 | 3.98B | 1.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.29B |
| GSK plc | 60.24B |
| Haleon | 30.25B |
| Smith & Nephew | 11.86B |
| Hikma Pharmaceuticals | 3.62B |
| HUTCHMED (China) | 2.19B |
| Genus | 1.62B |
| Oxford Nanopore Technologies | 1.52B |